WallStreetZenWallStreetZen

NASDAQ: SXTP
60 Degrees Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SXTP

Based on 2 analysts offering 12 month price targets for 60 Degrees Pharmaceuticals Inc

Min Forecast
$2.80+227.87%
Avg Forecast
$4.40+415.22%
Max Forecast
$6.00+602.58%

Should I buy or sell SXTP stock?

Based on 2 analysts offering ratings for 60 Degrees Pharmaceuticals Inc.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SXTP stock forecasts and price targets.

SXTP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-28
lockedlocked$00.00+00.00%2025-11-14

1 of 1

Forecast return on equity

Is SXTP forecast to generate an efficient return?

Company
N/A
Industry
252.48%
Market
228.08%

Forecast return on assets

Is SXTP forecast to generate an efficient return on assets?

Company
N/A
Industry
90.65%

SXTP earnings per share forecast

What is SXTP's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$3.36
Avg 2 year Forecast
-$1.76
Avg 3 year Forecast
-$0.48

SXTP revenue forecast

What is SXTP's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$1.7M+36.33%
Avg 2 year Forecast
$2.1M+69.88%
Avg 3 year Forecast
$3.9M+213.37%
SXTP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SXTP revenue growth forecast

How is SXTP forecast to perform vs Biotechnology companies and vs the US market?

Company
42.64%
Industry
101.28%
Market
25.62%
SXTP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SXTP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SXTP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SXTP$0.85$4.40+415.22%Buy
ONCO$2.30N/AN/A
AZTR$0.35N/AN/A
PHGE$2.28$26.00+1,040.35%Buy
OGEN$0.91N/AN/A
View Top Biotech Stocks

60 Degrees Pharmaceuticals Stock Forecast FAQ

Is 60 Degrees Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SXTP) stock is to Buy SXTP stock.

Out of 2 analysts, 0 (0%) are recommending SXTP as a Strong Buy, 2 (100%) are recommending SXTP as a Buy, 0 (0%) are recommending SXTP as a Hold, 0 (0%) are recommending SXTP as a Sell, and 0 (0%) are recommending SXTP as a Strong Sell.

If you're new to stock investing, here's how to buy 60 Degrees Pharmaceuticals stock.

What is SXTP's earnings growth forecast for 2025-2027?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.65%.

60 Degrees Pharmaceuticals's earnings in 2025 is -$8,470,732.On average, 4 Wall Street analysts forecast SXTP's earnings for 2025 to be -$14,196,537, with the lowest SXTP earnings forecast at -$14,054,394, and the highest SXTP earnings forecast at -$14,169,886. On average, 4 Wall Street analysts forecast SXTP's earnings for 2026 to be -$7,443,473, with the lowest SXTP earnings forecast at -$8,167,303, and the highest SXTP earnings forecast at -$6,574,116.

In 2027, SXTP is forecast to generate -$2,028,077 in earnings, with the lowest earnings forecast at -$1,948,544 and the highest earnings forecast at -$2,087,726.

What is SXTP's revenue growth forecast for 2025-2027?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's forecast annual revenue growth rate of 42.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.62%.

60 Degrees Pharmaceuticals's revenue in 2025 is $1,230,833.On average, 4 Wall Street analysts forecast SXTP's revenue for 2025 to be $7,098,692, with the lowest SXTP revenue forecast at $6,176,454, and the highest SXTP revenue forecast at $7,995,547. On average, 4 Wall Street analysts forecast SXTP's revenue for 2026 to be $8,845,867, with the lowest SXTP revenue forecast at $7,047,926, and the highest SXTP revenue forecast at $10,660,729.

In 2027, SXTP is forecast to generate $16,316,838 in revenue, with the lowest revenue forecast at $15,673,810 and the highest revenue forecast at $16,794,879.

What is SXTP's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SXTP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 90.65%.

What is SXTP's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SXTP price target, the average SXTP price target is $4.40, with the highest SXTP stock price forecast at $6.00 and the lowest SXTP stock price forecast at $2.80.

On average, Wall Street analysts predict that 60 Degrees Pharmaceuticals's share price could reach $4.40 by Nov 28, 2026. The average 60 Degrees Pharmaceuticals stock price prediction forecasts a potential upside of 415.22% from the current SXTP share price of $0.85.

What is SXTP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's current Earnings Per Share (EPS) is -$0.32. On average, analysts forecast that SXTP's EPS will be -$3.36 for 2025, with the lowest EPS forecast at -$3.32, and the highest EPS forecast at -$3.35. On average, analysts forecast that SXTP's EPS will be -$1.76 for 2026, with the lowest EPS forecast at -$1.93, and the highest EPS forecast at -$1.55. In 2027, SXTP's EPS is forecast to hit -$0.48 (min: -$0.46, max: -$0.49).

What is SXTP's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SXTP) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.